Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs
November 14, 2022 YPrime

Adoption of decentralized clinical trials (DCTs) and other alternatives to conventional clinical trials have accelerated in the past two years. Drug development companies have increased their efforts to implement new tools to help educate patients about participating in clinical trials, obtain consent, collect patient data, monitor patient compliance, and manage clinical supplies. However, technology implementation does not always go smoothly without first taking user perspectives into account while developing these technologies and re-examining and adapting clinical trial strategies. This eBook contains several articles that provide needed insights for sponsors who are considering, selecting, or implementing digital technologies for patient-centric clinical trials.

eBOOK

Strategies and Technologies that Empower DCTs

November 2022

RELATED CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Facilitating DCT with DtP Trial Strategy

Facilitating DCT with DtP Trial Strategy

LATEST CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Put the power in the hands of patients with YPrime eConsent

Put the power in the hands of patients with YPrime eConsent

YPrime Launches eConsent Solution